Professor Mohamed Shamji Assumes Presidency of EAACI as Congress 2026 Concludes in Istanbul

ISTANBUL, June 19 (Bernama) -- The European Academy of Allergy and Clinical Immunology (EAACI) has successfully concluded its Annual Congress 2026 in Istanbul, bringing together 7,429 delegates from 110 countries under the theme "Vision Zero: A Future Free from Allergy and Asthma Burden."

Over four days of scientific exchange, collaboration and education, the Congress showcased the latest advances in allergy, asthma, and clinical immunology, with 2,420 scientific abstracts presented by researchers from around the world. The programme highlighted emerging developments in precision medicine, immunotherapy, disease prevention, environmental health, digital innovation and patient-centred care, reflecting the growing momentum towards reducing the global burden of allergic diseases.